Customer Hotline:

+1 6193853151

Home > News > Company News
FY Bio Inc. is excited to participate in CTAD25 – San Diego, Dec 1–4, 2025!
Writer:Sam  |  Release time: 2025-12-02  |  132 Views
Connect with us at CTAD25 to explore how FY BIO can accelerate your next biopharmaceutical breakthrough. #CTAD25 #Bioprocess #Biopharma #FYBIO #CellTherapy #GeneTherapy #RecombinantProteins


As the official U.S. partner and exclusive representative of Biolink®, FY BIO provides end-to-end bioprocess solutions for recombinant proteins, vaccines, monoclonal antibodies, and advanced cell & gene therapies.


From high-performance cell culture platforms to chromatography systems, filtration modules, and GMP-compliant quality control, our integrated solutions empower biopharma companies to innovate faster and scale efficiently.


With offices across the U.S. (San Diego, Boston, Dallas, New Jersey), FY BIO combines global expertise with local support, ensuring seamless consultation, process design, implementation, and after-sales service.


Connect with us at CTAD25 to explore how FY BIO can accelerate your next biopharmaceutical breakthrough.
#CTAD25 #Bioprocess #Biopharma #FYBIO #CellTherapy #GeneTherapy #RecombinantProteins

Previous article:FY BIO – North America Weekly Update | Collaborations, Conferences & Industry Insights Next article:FY BIO is excited to participate in the 2025 AABB Annual Meeting
+1 6193853151
Tel